Back to search
FDAFDA · Food and drugs·Recall number D-0287-2025

PRASUGREL TABLETS, 5 mg, 30 tablet bottles, Rx only, packaged by GSMS, Incorporated, Camarillo, CA 93012 NDC 51407-444-30

Published March 26, 2025 · Recall initiated: March 5, 2025

Summary

FDA records drug Class II recall D-0287-2025, published March 26, 2025 and initiated March 5, 2025. Recalling firm: Golden State Medical Supply Inc.; Status: Ongoing; Reported quantity: 2,601 30-count bottles; Lot: Lot no's: GS059908, GS060228, GS060709, GS061233, GS061704, GS062158, GS062405, Exp.: 04/30/2026. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Dissolution Specifications

What to do

Voluntary: Firm initiated · Letter

Get an email if PRASUGREL has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
PRASUGREL
Manufacturer
Golden State Medical Supply Inc.
Distributor
U.S. Nationwide
Lot
Lot no's: GS059908, GS060228, GS060709, GS061233, GS061704, GS062158, GS062405, Exp.: 04/30/2026
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was PRASUGREL TABLETS, 5 mg, 30 tablet bottles, Rx only, packaged by GSMS, Incorporated, Camarillo, CA 93012 NDC 51407-444-30 recalled?

Yes. FDA published recall D-0287-2025 on March 26, 2025. Reported hazard: Failed Dissolution Specifications

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: PRASUGREL.